...
首页> 外文期刊>Letters in drug design & discovery >The Identification of New CD38 Inhibitors by Combined Structure and Ligand Based Virtual Screening Approaches of ZINC Database
【24h】

The Identification of New CD38 Inhibitors by Combined Structure and Ligand Based Virtual Screening Approaches of ZINC Database

机译:通过组合结构和基于锌数据库的虚拟筛选方法鉴定新的CD38抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Cluster of differentiation 38 (CD38) is major NADase and regulates the intracellular level of NAD. It uses NAD as substrate to produce ADP Ribose (ADPR) and cyclic ADP ribose (cADPR) and converts NADP to NAADP. Its inhibition can be utilized to treat several condition.
机译:背景:分化38(CD38)是主要的NADASE,并调节NAD的细胞内水平。 它使用NAD作为底物以产生ADP核糖(ADPR)和循环ADP核糖(CADPR)并将NADP转化为NAADP。 它的抑制可以用于治疗几种条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号